Pillstats
Rx only · Injection · Intramuscular

Phenobarbital Sodium

Phenobarbital Sodium

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8134
US makers4 labelers
Packages23
DEA / ScheduleCIV

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6561.3K2.0K2.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.3K
Rx · 2026 Q1
6.9K
Units dispensed
-44%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager11SUPPLYING
Cameron Pharmaceuticalsunknown6SUPPLYING
BPI Labs LLCunknown4SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 14, 2022
    RECALLRecall (Class II): PHENOBARBITAL Sodium Injection, USP, 65mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-415-25) and b) 3 x 1 mL…

    Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. — Recalling firm: Vitae Enim Vitae Scientific, Inc. — Nationwide in the U.S.A

  • Mar 14, 2022
    RECALLRecall (Class II): PHENOBARBITAL Sodium Injection, USP, 130 mg/mL, packaged as a) 25 x 1 mL Vials per box (NDC 42494-416-25) and b) 3 x 1m…

    Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile. — Recalling firm: Vitae Enim Vitae Scientific, Inc. — Nationwide in the U.S.A